Hereditary breast cancer beyond BRCA: Clinical and histopathological characteristics in patients with germline CHEK2, ATM, PALB2 and TP53-mutations

被引：1
|
作者：
Hoste, G. [1 ]
D'Hoore, P. [1 ]
Legius, E. [1 ]
Van Buggenhout, G. [1 ]
Floris, G. [1 ]
Wildiers, H. [1 ]
Han, S. N. [1 ]
Van Nieuwenhuysen, E. [1 ]
Berteloot, P. [1 ]
Smeets, A. [1 ]
Nevelsteen, I. [1 ]
Weltens, C. [1 ]
Janssen, H. [1 ]
Van Limbergen, E. [1 ]
Neven, P. [1 ]
Punie, K. [1 ]
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P5-09-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-09-05
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Clinical outcomes of treatment with CDK4/6 inhibitors in metastatic breast cancer among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
    Scheel, R.
    Choong, G. M.
    Koch, R.
    Yadav, S. K.
    Karki, A.
    Rao, R.
    Boddicker, N. J.
    Hu, C.
    Na, J.
    Kaggal, V.
    Murphy, S.
    Giridhar, K. V.
    Yasir, S.
    Goetz, M. P.
    Couch, F. J.
    Yadav, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S364 - S364
  • [22] BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma
    Pennington, Kathryn P.
    Walsh, Tom
    Lee, Ming
    Pennil, Christopher
    Novetsky, Akiva P.
    Agnew, Kathy J.
    Thornton, Anne
    Garcia, Rochelle
    Mutch, David
    King, Mary-Claire
    Goodfellow, Paul
    Swisher, Elizabeth M.
    CANCER, 2013, 119 (02) : 332 - 338
  • [23] Surgical decision making and clinical outcomes in breast cancer (BC) patients (pts) with germline alterations in moderate risk BC susceptibility genes (CHEK2, PALB2 and ATM)
    dos Anjos, Carlos Henrique
    Amoros, Kimberly
    Pilewskie, Melissa
    Braunstein, Lior
    Robson, Mark
    CANCER RESEARCH, 2020, 80 (04)
  • [24] Clinical Presentation and Management Considerations for Breast Cancer Patients With Germline PALB2 Mutations
    Vikstrom, Karen
    Fulbright, Jennifer
    Michalski, Scott
    Yang, Shan
    Lincoln, Steve
    Esplin, Ed
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : 166 - 166
  • [25] Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
    Haeyoung Kim
    Dae-Yeon Cho
    Doo Ho Choi
    Mijin Oh
    Inkyung Shin
    Won Park
    Seung Jae Huh
    Seok Jin Nam
    Jeong Eon Lee
    Seok Won Kim
    Breast Cancer Research and Treatment, 2017, 161 : 95 - 102
  • [26] PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
    Southey, Melissa C.
    Goldgar, David E.
    Winqvist, Robert
    Pylkas, Katri
    Couch, Fergus
    Tischkowitz, Marc
    Foulkes, William D.
    Dennis, Joe
    Michailidou, Kyriaki
    van Rensburg, Elizabeth J.
    Heikkinen, Tuomas
    Nevanlinna, Heli
    Hopper, John L.
    Doerk, Thilo
    Claes, Kathleen B. M.
    Reis-Filho, Jorge
    Teo, Zhi Ling
    Radice, Paolo
    Catucci, Irene
    Peterlongo, Paolo
    Tsimiklis, Helen
    Odefrey, Fabrice A.
    Dowty, James G.
    Schmidt, Marjanka K.
    Broeks, Annegien
    Hogervorst, Frans B.
    Verhoef, Senno
    Carpenter, Jane
    Clarke, Christine
    Scott, Rodney J.
    Fasching, Peter A.
    Haeberle, Lothar
    Ekici, Arif B.
    Beckmann, Matthias W.
    Peto, Julian
    dos-Santos-Silva, Isabel
    Fletcher, Olivia
    Johnson, Nichola
    Bolla, Manjeet K.
    Sawyer, Elinor J.
    Tomlinson, Ian
    Kerin, Michael J.
    Miller, Nicola
    Marme, Federik
    Burwinkel, Barbara
    Yang, Rongxi
    Guenel, Pascal
    Therese Truong
    Menegaux, Florence
    Sanchez, Marie
    JOURNAL OF MEDICAL GENETICS, 2016, 53 (12) : 800 - 811
  • [27] Oncotype DX Breast Recurrence Score® analysis in early-stage breast cancer associated with CHEK2, ATM and PALB2 germline pathogenic variants
    Mustafayev, Fatma Akkoc
    Barrera, Angelica Gutierrez
    Liu, Diane
    Arun, Banu
    CANCER RESEARCH, 2024, 84 (09)
  • [28] Comprehensive Sequencing of PALB2 in Patients With Breast Cancer Suggests PALB2 Mutations Explain a Subset of Hereditary Breast Cancer
    Fernandes, Priscilla H.
    Saam, Jennifer
    Peterson, Jenny
    Hughes, Elisha
    Kaldate, Rajesh
    Cummings, Shelly
    Theisen, Aaron
    Chen, Sonia
    Trost, Jeffrey
    Roa, Benjamin B.
    CANCER, 2014, 120 (07) : 963 - 967
  • [29] Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
    Kim, Haeyoung
    Cho, Dae-Yeon
    Choi, Doo Ho
    Oh, Mijin
    Shin, Inkyung
    Park, Won
    Huh, Seung Jae
    Nam, Seok Jin
    Lee, Jeong Eon
    Kim, Seok Won
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 95 - 102
  • [30] Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
    Lukomska, Alicja
    Menkiszak, Janusz
    Gronwald, Jacek
    Tomiczek-Szwiec, Joanna
    Szwiec, Marek
    Jasiowka, Marek
    Blecharz, Pawel
    Kluz, Tomasz
    Stawicka-Nielacna, Malgorzata
    Madry, Radoslaw
    Bialkowska, Katarzyna
    Prajzendanc, Karolina
    Kluzniak, Wojciech
    Cybulski, Cezary
    Debniak, Tadeusz
    Huzarski, Tomasz
    Toloczko-Grabarek, Aleksandra
    Byrski, Tomasz
    Baszuk, Piotr
    Narod, Steven A.
    Lubinski, Jan
    Jakubowska, Anna
    CANCERS, 2021, 13 (04) : 1 - 11
12345